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Abstract
Background: It has been shown that gene polymorphisms may play an important role in the carcinogenesis of
esophageal cancer. This study is to investigate the role of alcohol dehydrogenase 1B (ADH1B) gene Arg47His
polymorphism in esophageal cancer susceptibility.
Methods: Case-control studies published between January 2000 and June 2015 were searched to retrieve
relevant articles. The pooled odds ratio (OR) and 95 % confidence interval (CI) were employed to calculate the
strength of association.
Results: A total of 23 relevant articles were finally selected for the analysis, including 9338 esophageal cancer
patients and 14,896 matched controls. Overall, we found that the 47His allele was significant associated with the
decreased risk of esophageal cancer when compared with the 47Arg allele in total populations (A vs. G: OR = 0.
67, 95 % CI = 0.59–0.76, P < 0.00001). This protective relationship was observed under other genetic models as well
(P < 0.00001). Subgroup analysis by ethnicity showed that ADH1B Arg47His variant was associated with the decreased
esophageal cancer risk under all the genetic models (P < 0.00001) among Asians, especially in Chinese and Japanese;
while in non-Asians, no significant correlation was detected in any genetic models (P > 0.05). Furthermore, Arg/Arg
genotype of ADH1B Arg47His variant combined with drinking, smoking and males appeared to show a high risk in
patients with esophageal cancer.
Conclusions: Our results suggested that ADH1B gene Arg47His variant was associated with the decreased esophageal
cancer risk. Genetic-environmental interaction should be further considered in the future researches.
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Background
Esophageal cancer (or oesophageal cancer), a type of
cancer arising from the esophagus, is the eighth most
common cancer and the sixth leading cause of cancer-
related death worldwide [1]. Squamous cell carcinomas
(SCC), which is more common in the developing world,
and adenocarcinomas (AC), which is more common in
the developed world, are two main forms of histologi-
cally confirmed esophageal cancer [2, 3]. The clinical
symptoms include difficulty in swallowing, enlarged
lymph glands around the collarbone, a dry cough, weight
loss, and possibly hematemesis [4]. The established risk
factors for this disease are environmental factors (alco-
hol drinking, smoking, infecting bacteria or virus), gen-
etic factors (mutations in enzymes that metabolize
alcohol), cultural factors (high-temperature food items
such as pork braised in brown sauce and old stocked
rice), obesity and gastroesophageal reflux [5–8]. The in-
cidence of esophageal cancer is threefold higher in men
than women [9] and is high in east Asia, southern
Africa, and southern Europe while is low in North
America and other parts of Europe [10]. The highest re-
ported incidence and mortality rates occur in China,
which is almost 20 to 30 times higher than that in the
USA [11]. According to cancer statistics, there will be an
estimated 16,980 new cases and 15,590 deaths in both
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sexes in the USA in 2015 [12]. Although many advances
in diagnosis and treatment such as endoscopic resection,
chemotherapy, and surgery have the potential to sub-
stantially reduce mortality and morbidity [13, 14], the
prognosis of patients with esophageal cancer remains
poor and the 5-year survival rate is still low, ranging
from 15 to 25 % [15, 16]. Therefore, identifying new bio-
markers for early diagnosis and treatment is vital to
decide therapeutic options, improve treatment efficiency,
and predict prognosis [17].
Evidences have shown that gene polymorphisms may
play an important role in the carcinogenesis of esopha-
geal cancer [18]. Alcohol dehydrogenase gene (ADH), at
chromosome 4, is a key cytosolic enzyme for ethanol
[19]. It encodes at least seven ADH isoforms (ADH1–
ADH7), each with slightly different properties [20], and
may be involved in the metabolic pathways of several
neurotransmitters [21]. The ADH1B (also known as
ADH2) gene is located on human chromosome 4q21-
q23. It is the locus responsible for most of the ADH
activity on ethanol in the liver [22]. Single nucleotide
polymorphisms (SNPs) occurring in this gene may be
capable of altering ethanol metabolism, and individuals
expressing the ADH1B variants would have different
alcohol elimination rates [23]. One of the most studied
SNP was Arg47His (rs1229984), a G to A base transition
in exon 3 leading to the substitution of arginine
(ADH1B*1) to histidine (ADH1B*2) at codon 47th pos-
ition. ADH1B*2 is common in more than 90 % of Asians
and reduced their risk for alcoholism but fewer than
20 % of Caucasians or Africans [24]. This variant was
shown to be strongly associated with alcohol depend-
ence, abuse, consumption, and alcohol-induced liver
diseases [25, 26].
Several studies have identified the relationship between
ADH1B polymorphism and esophageal cancer susceptibil-
ity, but the consistent results were not obtained. For ex-
ample, Ito et al. demonstrated that ADH1B Arg47His
variant was associated with esophageal cancer in Japanese
and might be used in personalized prevention programs
[27], while Ma et al. did not show significant associations
between variations in the ADH1B gene and esophageal
squamous cell carcinoma (ESCC) risk in Chinese [28]. Al-
though previous meta-analyses were performed to evalu-
ate this association [29–31], limited articles were selected,
only Asian population was used for analysis, and some re-
peated participants were included. Furthermore, Asians
and Caucasians may have different incidence, distribu-
tion, and susceptibilities to esophageal cancer due to
different heritage backgrounds [32]. All these factors
may influence the reliable of the results. Therefore,
we conducted the present meta-analysis to review all
the published articles among any ethnicities to obtain
a relative reliable result.
Methods
Identification of relevant studies
Electronic databases of PubMed, Web of Science, Med-
line, Embase, CNKI (China National Knowledge Internet),
and Wanfang were comprehensively searched to retrieve
relevant articles published between January 2000 and June
2015. The MeSH terms were as follows: “esophageal can-
cer or oesophageal cancer or esophageal squamous cell
carcinomas or esophageal adenocarcinomas,” “alcohol de-
hydrogenase or ADH1B or ADH2,” and “polymorphism
or variant or mutation” as well as their combinations. The
equivalent Chinese characters were used in Chinese data-
base. We also manually searched the references of in-
cluded studies in order to obtain more related articles.
Our analysis only considered studies that were written in
English and Chinese.
Inclusion and exclusion criteria
The eligible articles must meet the following criteria.
The inclusion criteria were as follows: (1) case-control
studies evaluating the correlation of ADH1B Arg47His
polymorphism in esophageal cancer occurrence; (2) pat-
ents with esophageal cancer should be diagnosed clinic-
ally and confirmed histologically, the controls should be
age-, ethnicity-matched participants without malignancy
and digestive and chronic diseases; (3) the genotype
information were available to extract; and (4) the geno-
types of controls were consistent with Hardy-Weinberg
equilibrium (HWE). The exclusion criteria were as
follows: (1) duplicate articles from the same authors or
laboratories or conducted among the same populations;
(2) conference reports or reviews; (3) without control
group; and (4) data could not be extracted.
Data extraction
Two of our authors independently assessed the quality
of selected studies. Each item of a single study should be
achieved a final consensus. The extracted information
was as follow: the name of first author, published year,
country, ethnicity, mean age, sample size, genotype
method, alleles and genotypes distribution, source of
cases and controls, and HWE of genotypes in controls.
Statistical analysis
The pooled odds ratio (OR) with its 95 % confidence
interval (CI) were employed to estimate the association
between ADH1B Arg47His variant and esophageal car-
cinoma susceptibility. The Z test was used to determine
the significance of ORs, and P value was less than 0.05
considered as statistically significance. The allelic model
(His vs. Arg), the homologous model (His/His vs. Arg/
Arg), the heterogeneous model (Arg/His vs. Arg/Arg),
the dominant model (His/His+Arg/His vs. Arg/Arg) and
the recessive model (His/His vs. Arg/His+Arg/Arg) were
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examined. The Q test and the I2 test were used to assess
the degree and proportion of between-study hetero-
geneity, respectively. The fixed-effect model was used
when the P value of the Q test was more than 0.10
and the I2 of the I2 test was less than 50 %; other-
wise, the random-effect model was used. All statistical
analyses were conducted in Review Manager 5.2 (the
Cochrane Collaboration, Oxford, England). All the
tests were two-sided.
Results
Characteristics of included studies
We firstly identified 105 articles. After the inclusion
and exclusion criteria filtering, a total of 23 relevant
articles were finally screened out, including 9338
esophageal cancer patients and 14,896 matched con-
trols. Figure 1 presented the selection process. Of the
23 articles, two were written in Chinese [33, 34] and
21 were in English [35–55]. The participants of
Hashibe et al.’s study were from five countries
(Romania, Poland, Russia, Slovakia, and Czech Repub-
lic) [38], while other studies were from seven coun-
tries (Japan, Thailand, Iran, Kashmir, Sudan, Dutch
and China), respectively. There were two sources of
controls: population-based controls and hospital-
based controls. The ADH1B Arg47His variant was
measured in eight methods. Table 1 listed the main
characteristics of included studies. Table 2 displayed
the alleles and genotypes information of ADH1B
Arg47His variant in each included studies.
Overall association between ADH1B Arg47His polymorphism
and esophageal cancer risk
A significant heterogeneity among all the included stud-
ies was observed (P < 0.01 and I2 > 50 %), and the
random-effect model was used. Table 3 listed the results
of the association between the ADH1B Arg47His poly-
morphism and esophageal cancer susceptibility. Overall,
we found that the frequency of 47His allele was higher
than the 47Arg allele in both cases and controls, and the
statistical analysis demonstrated that the 47His allele was
significant associated with the decreased risk of esopha-
geal cancer in total populations (His vs. Arg: OR = 0.67,
95 % CI = 0.59–0.76, P < 0.00001) as shown in Fig. 2. This
significant protective relationship was also identified
under other genetic models (P < 0.00001). Subgroup ana-
lysis by ethnicity showed that this polymorphism revealed
an ethnic difference and geographic variance. In Asians,
ADH1B 47His variant was shown to be associated with
the decreased esophageal cancer risk under all the genetic
models (P < 0.00001); while in non-Asians, no significant
correlation was detected in any genetic models (P > 0.05).
Figure 3 showed the result of the His carriers of the His/
His and Arg/His genotypes compared with the Arg/Arg
genotype in both groups. Furthermore, we also considered
the role of this genetic variant in esophageal cancer
among different countries. There were 12 articles in China
(5485 patients and 6982 controls), five in Japan (2319 pa-
tients and 5213 controls), and six in other countries. Our
result demonstrated that ADH1B Arg47His variant was a
protective factor for cancer risk in Chinese and Japanese
populations as shown in Fig. 4.
Fig. 1 Flow diagram of the selection process
Mao et al. World Journal of Surgical Oncology  (2016) 14:191 Page 3 of 13
Combined effect of ADH1B Arg47His variant and alcohol
drinking, tobacco smoking, and gender difference on
esophageal cancer risk
Fifteen studies estimated the combined effect of
ADH1B Arg47His polymorphism and alcohol drinking
on esophageal cancer risk. However, the relevant data
could be extracted only from 12 studies, including
3545 patients and 6909 controls. Based on these data,
we could only assess the combined effect on esopha-
geal cancer susceptibility under the Arg/Arg versus
His/His+Arg/His model. We divided the subjects into
two groups: non-drinking group (1134 cases and
3526 controls) and drinking group (2411 cases and
3383 controls). Our results found that Arg/Arg
genotype compared with the His carrier of His/His
and Arg/His genotypes was significantly associated
with the increased higher risk of esophageal cancer
in the drinking group (OR = 3.15, 95 % CI = 2.66–
3.74, P < 0.00001) and lower in the non-drinking
group (OR = 1.71, 95 % CI = 1.23–2.38, P = 0.001) as
shown in Fig. 5.
Four articles considered the combined effect of
ADH1B Arg47His polymorphism and tobacco smoking
on esophageal cancer susceptibility, containing 2382
patients and 4792 controls. Our result demonstrated
that the Arg/Arg genotype was associated with esopha-
geal cancer occurrence in both non-smokers (OR = 2.40,
95 % CI = 1.44–3.98, P = 0.0007) and smokers (OR =
3.35, 95 % CI = 2.22–5.05, P < 0.00001) in the random-
effect model as shown in Fig. 6, and this relationship
was a bit stronger in smokers than that in non-smokers.
Six articles were selected for gender variance (five for
males and two for females). Our result showed that the
Arg/Arg genotype of ADH1B Arg47His variant in-
creased the esophageal cancer risk in male patients
(OR = 3.44, 95 % CI = 2.42–4.89, P < 0.0001), while not
in female patients (OR = 1.62, 95 % CI = 0.90–2.91, P =
0.11) as shown in Fig. 7.
Table 1 Main characteristics of included studies in this meta-analysis
First author Year Country Ethnicity Mean age Sample size Source of Genotyping
methodsCases Controls Cases Controls Cases Controls
Yokoyama A 2001 Japan Asian 56 ± 7 53 ± 8 112 526 ESCC HB PCR-RFLP
Boonyaphiphat P 2002 Thailand Asian 64.0 ± 9.7 64.5 ± 12.3 202 261 ESCC HB APLP
Chao YC 2003 China (Taiwan) Asian 64.6 ± 12.3 53.0 ± 18.8 88 105 EC HB PCR-RFLP
Yokoyama T 2003 Japan Asian 61.7 ± 7.9 58.9 ± 7.1 233 610 ESCC PB PCR-RFLP
Chen HG 2005 China Asian 58.06 (35–80) 58.53 (35–82) 137 137 EC PB PCR
Yang CX 2005 Japan Asian 61.4 ± 0.6 61.4 ± 0.4 165 495 ESCC/EAC HB PCR-CTPP
Hashibe M 2006 Mixed Caucasian 56.7 ± 2.1 58.9 ± 3.4 167 887 ESCC PB TaqMan
Yang SJ 2007 China Asian 58.3 ± 8.3 52.8 ± 13.2 191 198 EC PB PCR-CTPP
Guo YM 2008 China Asian 60.2 ± 8.9 59.7 ± 9.7 80 480 ESCC PB PCR-RFLP
Lee CH 2008 China (Taiwan) Asian 60.2 ± 3.8 61.3 ± 3.9 406 656 ESCC HB PCR-RFLP
Akbai 2009 Iran Asian 63.6 (25–89) 55.2 (24–90) 746 1373 ESCC PB Sequenom
Cui R 2009 Japan Asian 64.2 ± 8.7 59.7 ± 16.2 1070 2836 ESCC PB BeadChip
Ding JH 2010 China Asian 68.2 ± 5.6 69.8 ± 7.3 221 191 EC PB PCR-DHPLC
Tanaka F 2010 Japan Asian 67.2 ± 7.3 66.5 ± 7.2 742 820 OSCC PB BRLMM
Iqbal B 2011 Kashmir Asian NA NA 50 50 EC PB Sequencing
Wang YL 2011 China Asian 57.2 ± 9.4 56.1 ± 7.3 81 162 EC PB PCR-CTPP
Gu HY 2012 China Asian 62.5 ± 6.2 63.8 ± 7.1 380 380 ESCC HB MALDI-ToF-MS
Dura P 2013 Dutch Caucasian 65.0 ± 10.9 64.9 ± 11.1 351 430 ESCC/EAC PB TaqMan
Gao Y 2013 China Asian NA NA 2139 2273 ESCC PB TaqMan
Wu M 2013 China Asian 63.7 ± 9.4 63.7 ± 10.3 846 1079 EC PB Sequencing
Hou AM 2014 China Asian 56.5 ± 5.5 58.7 ± 6.3 110 110 ESCC/EAC PB PCR-RFLP
Ye B 2014 China Asian 58.7 ± 6.4 59.9 ± 7.2 1001 1391 ESCC HB PCR-RFLP
Babiker H 2015 Sudan Africa 56.41 47.87 134 233 ESCC/EAC PB PCR-RFLP
NA not available, ESCC esophageal squamous cell carcinoma, EAC esophageal adenocarcinoma, OSCC oesophageal squamous cell carcinoma, HB hospital-based, PB
population-based, NP normal healthy population, APLP amplified product length polymorphism method, PCR-CTPP polymerase chain reaction with the confronting two-pair
primer, PCR-DHPLC polymerase chain reaction and denaturing high-performance liquid chromatography, BRLMM Bayesian robust linear model with Mahalanobis algorithm,
MALDI-ToF-MSmatrix-assisted laser desorption/ionization-time-of-flight mass spectrometry
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Sensitivity analysis and publication bias
We deleted a single included study at a time to verify
whether our results were influenced by each study.
The result showed that even though the between-
study heterogeneity was reduced, the pooled ORs were
not significantly changed, indicating that there was no
publication bias in the present meta-analysis. The fun-
nel plot among the total population under the domin-
ant model further reveal no publication bias as shown
in Fig. 8.
Discussion
In this meta-analysis, we totally screened out 23 relevant
articles. Our results showed that the ADH1B Arg47His
variant was correlated with the decreased occurrence of
esophageal cancer under all the genetic models among
total population. Subgroup analysis by ethnicity demon-
strated that this variant was associated with the decreased
cancer risk in Asian populations as well, especially in
Chinese and Japanese. However, in non-Asian population,
no significant relationship was observed. Furthermore, we
found that the combined effect of Arg/Arg genotype in
ADH1B Arg47His variant and alcohol drinking, tobacco
smoking, and male patients revealed a higher risk on
esophageal cancer risk when compared with the His
carrier of His/His and Arg/His genotypes, respectively.
Our results were consistent with previous meta-analyses
which showed that ADH1B*47Arg could significantly in-
crease the risk of ESCC in Asians, especially when coupled
with alcohol drinking [29–31].
Esophageal cancer is considered as a serious malig-
nancy worldwide for its extremely aggressive nature and
poor survival rate [56]. It is a multistep, multifactorial
disease, and the incidence is varied due to the geograph-
ical diversities; thus, the therapeutic management might
be different as well. Genetic variations might be involved
in esophageal cancer development and predict the prog-
nosis [57]. Studies have shown that ADH gene might
play a role in carcinogenesis. ADH constitutes a large
family of enzymes and is a metabolic barrier against self-
administer ethanol [58]. ADH isoenzyme is responsible
for the reversible oxidation of alcohols to acetaldehyde,
Table 2 Distribution of alleles and genotypes in each included studies
First author Cases Controls
Arg/Arg Arg/His His/His Arg His Arg/Arg Arg/His His/His Arg His HWE
(*1/*1) (*1/*2), (*2/*2) (*1) (*2) (*1/*1) (*1/*), (*2/*2) (*1) (*2)
Yokoyama A 56 56* – – 145 381* – –
Boonyaphiphat P 101 86 15 288 116 94 139 28 327 195 0.08
Chao YC 19 41 28 79 97 7 43 55 57 153 0.94
Yokoyama T 51 73 109 175 291 31 212 367 274 946 0.99
Chen HG 26 54 57 106 168 14 49 74 77 197 0.40
Yang CX 6 85 74 97 233 22 168 304 212 776 0.98
Hashibe M 163 4* – – 792 95* – – –
Yang SJ 33 80 78 146 236 22 76 100 120 276 0.44
Guo YM 17 25 38 59 101 24 168 288 216 744 0.99
Lee CH 117 149 140 383 429 46 275 335 367 945 0.59
Akbai 21 232 490 274 1212 73 471 827 617 2125 0.86
Cui R 194 363 510 751 1383 151 986 1626 1288 4238 0.99
Ding JH 19 96 106 134 308 8 75 108 91 291 0.53
Tanaka F 149 237 356 535 949 49 287 484 385 1255 0.76
Iqbal B 12 36 2 60 40 12 37 1 61 39 0.30
Wang YL 15 34 33 64 100 17 67 78 101 223 0.90
Gu HY 53 168 158 274 484 26 170 182 222 534 0.26
Dura P 326 20 0 672 20 406 23 0 835 23 0.85
Gao Y 252 907 939 1411 2785 199 909 1155 1307 3219 0.57
Wu M 138 309 355 585 1019 101 410 510 612 1430 0.38
Hou AM 59* 51 – – 48* 62 – – –
Ye B 224 400 377 848 1154 150 578 663 878 1904 0.36
Babiker H 115 8 2 238 12 188 18 4 394 26 0.06
HWE Hardy-Weinberg Equilibrium;–, not applicable; *for Yokoyama A and Hashibe M means His/His+Arg/His; *for Hou AM means Arg/His+Arg/Arg
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Table 3 Meta-analysis of the overall association between ADH1B Arg47His polymorphism and esophageal cancer risk
Classification Comparisons Number of included studies Test of association Test of heterogeneity
OR (95 % CI) P Ph I2 Model
Total His vs. Arg 20 0.67 (0.59, 0.76) <0.00001 <0.00001 87 % R
His/His vs. Arg/Arg 20 0.40 (0.30, 0.54) <0.00001 <0.00001 86 % R
Arg/His vs. Arg/Arg 20 0.52 (0.40, 0.68) <0.00001 <0.00001 85 % R
His/His+Arg/His vs. Arg/Arg 22 0.46 (0.36, 0.59) <0.00001 <0.00001 86 % R
His/His vs. Arg/His+Arg/Arg 21 0.69 (0.61, 0.77) <0.00001 <0.00001 69 % R
Asian His vs. Arg 18 0.66 (0.57, 0.75) <0.00001 <0.00001 88 % R
His/His vs. Arg/Arg 18 0.40 (0.30, 0.54) <0.00001 <0.00001 87 % R
Arg/His vs. Arg/Arg 18 0.49 (0.38, 0.65) <0.00001 <0.00001 86 % R
His/His+Arg/His vs. Arg/Arg 19 0.44 (0.34, 0.58) <0.00001 <0.00001 87 % R
His/His vs. Arg/His+Arg/Arg 19 0.68 (0.61, 0.77) <0.00001 <0.00001 71 % R
Non-Asian His vs. Arg 2 0.93 (0.59, 1.47) 0.75 0.46 0 % F
His/His vs. Arg/Arg 1 0.82 (0.15, 4.53) 0.82 NA NA
Arg/His vs. Arg/Arg 2 0.95 (0.57, 1.56) 0.83 0.46 0 % F
His/His+Arg/His vs. Arg/Arg 3 0.59 (0.23, 1.48) 0.26 0.02 75 % R
His/His vs. Arg/His+Arg/Arg 1 0.84 (0.15, 4.64) 0.84 NA NA
China His vs. Arg 11 0.64 (0.56, 0.73) <0.00001 <0.00001 78 % R
His/His vs. Arg/Arg 11 0.37 (0.29, 0.50) <0.00001 <0.00001 79 % R
Arg/His vs. Arg/Arg 11 0.47 (0.35, 0.63) <0.00001 <0.00001 77 % R
His/His+Arg/His vs. Arg/Arg 11 0.41 (0.31, 0.55) <0.00001 <0.00001 80 % R
His/His vs. Arg/His+Arg/Arg 12 0.71 (0.66, 0.76) <0.00001 0.16 29 % F
Japan His vs. Arg 4 0.55 (0.51, 0.60) <0.00001 0.41 0 % F
His/His vs. Arg/Arg 4 0.26 (0.18, 0.38) <0.00001 0.03 66 % R
Arg/His vs. Arg/Arg 4 0.35 (0.21, 0.59) <0.00001 0.0008 82 % R
His/His+Arg/His vs. Arg/Arg 5 0.31 (0.22, 0.44) <0.00001 0.004 74 % R
His/His vs. Arg/His+Arg/Arg 4 0.62 (0.56, 0.69) <0.00001 0.65 0 % F
NA not applicable, OR odds ratio, 95 % CI 95 % confidence interval, Ph and I2 test of heterogeneity, F fixed-effect model, R random-effect model
Fig. 2 Meta-analysis of ADH1B Arg47His polymorphism and esophageal cancer risk in a random-effect model under the allelic models (His vs. Arg)
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which is in turn oxidized to aldehyde by aldehyde dehy-
drogenases (ALD) [59]. ADH1B and ALDH2 are the
major enzymes involved in the alcohol-metabolizing path-
ways in humans. ADH1B is one member of ADH family
and is expressed in the liver and presented in gastrointes-
tinal tract. This gene is mainly contributed for ethanol to
carcinogenic metabolite conversion during the elimination
phage [60]. In addition, ADH1B expression could result in
high blood acetaldehyde levels, which can easily give rise
to DNA damage, and finally cause the cancer occurrence
[61]. Genetic polymorphisms of ADH1B could modulate
exposure levels to ethanol. ADH1B can include three al-
leles (ADH2*1, ADH2*2, and ADH2*3). Among which,
the Arg47His variant (ADH2*2) was the most studied.
The activity of ADH1B was increased by 40-fold in
ADH1B His/His individuals [62], resulting in the fast ac-
cumulation of acetaldehyde.
SNPs of ADH1B gene (the major alcohol-metabolizing
enzyme gene) may modify the effects of alcohol on meta-
bolic and clinical phenotypes [63]. Blood ethanol concen-
trations of ADH1B*2/*2 group were shown higher than
those of ADH1B*1/*2 group [64]. ADH1B allele was asso-
ciated with a reduction in alcohol consumption [65] and
might be an important protective factor for alcoholic liver
cirrhosis, especially for Asians [66]. ADH2*2 predicted less
drinking and was a protective effect against heavy drinking
in Jewish samples [67]. Heavy alcohol consumption and
heavy smoking were shown to be associated with the in-
creased risk of esophageal cancer particularly in individ-
uals with the flushing response [68].
Fig. 3 Subgroup analysis by ethnicity of ADH1B Arg47His polymorphism and esophageal cancer susceptibility under the dominant model (His/His+Arg/
His vs. Arg/Arg)
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Fig. 4 Association between ADH1B Arg47His polymorphism and esophageal cancer under the dominant model based on countries
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Fig. 5 Forest plot of the combined effect of ADH1B Arg47His polymorphism and alcohol drinking condition and esophageal cancer risk under the
Arg/Arg versus Arg/His+His/His model (a non-drinkers; b drinkers)
Fig. 6 Meta-analysis of the combined effect of ADH1B Arg47His polymorphism and smoking status and esophageal cancer risk under the Arg/Arg
versus Arg/His+His/His model
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Previous studies have found that ADH1B Arg47His
polymorphism was associated with the pathogenesis of
cancers such as colorectal cancer [69] and head and
neck cancer [70], while no positive correlation was
found in hepatocellular carcinoma [71] and gastric can-
cer [72]. Several studies have identified the association
between ADH1B polymorphism and esophagus cancer
susceptibility. Chen et al. have observed that individuals
with ADH1BArg/Arg genotype had a 3.99-fold risk of
developing esophageal cancer compared with those with
ADH1B His/His genotype [73]. Li et al. have demon-
strated that ADH2*1 was associated with the increased
risk of oesophageal cancer, possibly due to the tolerance
of the carriers of these alleles to alcohol consumption
compared to those with high-activity alleles ADH2*2
which are associated with higher production of the
unpleasant acetaldehyde intermediate [74]. Oze et al.
found that the magnitude of effect of ADH1B polymor-
phisms was greater in subjects who were heavy drinkers,
heavy smokers, and had esophageal cancer [75]. Con-
sumption of tobacco and alcohol, coupled with ADH1B
genotypes, determines a substantial magnitude of tumor-
igenetic effect on earlier age ESCC diagnosis [76].
Several limitations were presented in this meta-
analysis. Firstly, most of the included studies were con-
ducted in the Asian population, while other ethnicities
should be considered in the future. Secondly, the stages
of patients with esophageal cancer could not be ex-
tracted from the included studies, which might limit the
application of our results. Thirdly, the combined effect
of ADH1B Arg47His variant and age group also should
be focused on. Lastly, other polymorphisms in ADH1B
Fig. 7 Forest plot of the combined effect of ADH1B Arg47His polymorphism and gender variance and esophageal cancer risk under the Arg/Arg
versus Arg/His+His/His model (a males; b females)
Fig. 8 Funnel plot of the publication bias in this meta-analysis under the dominant model in total population (His/His+Arg/His vs. Arg/Arg)
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gene or other ADH genes which might alter the metab-
olism of alcohol should be included.
Conclusions
In conclusion, our results suggested that ADH1B
Arg47His polymorphism might be a protective factor
on esophageal cancer susceptibility in Asians. The
Arg/Arg genotypes combined with alcohol drinking,
tobacco smoking, and males might be strongly in-
creased the risk of esophageal cancer. However, fur-
ther studies with more ethnicities should be taken into
account in future researches.
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